Literature DB >> 26452489

Adenosine A2A receptor activation is determinant for BDNF actions upon GABA and glutamate release from rat hippocampal synaptosomes.

Sandra Henriques Vaz1, Sofia Rapaz Lérias2, Sara Parreira2, Maria José Diógenes2, Ana Maria Sebastião2.   

Abstract

Adenosine, through A(2A) receptor (A(2A)R) activation, can act as a metamodulator, controlling the actions of other modulators, as brain-derived neurotrophic factor (BDNF). Most of the metamodulatory actions of adenosine in the hippocampus have been evaluated in excitatory synapses. However, adenosine and BDNF can also influence GABAergic transmission. We thus evaluated the role of A(2A)R on the modulatory effect of BDNF upon glutamate and GABA release from isolated hippocampal nerve terminals (synaptosomes). BDNF (30 ng/ml) enhanced K(+)-evoked [(3)H]glutamate release and inhibited the K(+)-evoked [(3)H]GABA release from synaptosomes. The effect of BDNF on both glutamate and GABA release requires tonic activation of adenosine A(2A)R since for both neurotransmitters, the BDNF action was blocked by the A(2A)R antagonist SCH 58261 (50 nM). In the presence of the A(2A)R agonist, CGS21680 (30 nM), the effect of BDNF on either glutamate or GABA release was, however, not potentiated. It is concluded that both the inhibitory actions of BDNF on GABA release as well as the facilitatory action of the neurotrophin on glutamate release are dependent on the activation of adenosine A(2A)R by endogenous adenosine. However, these actions could not be further enhanced by exogenous activation of A(2A)R.

Entities:  

Keywords:  Adenosine A2A receptors; Brain-derived neurotrophic factor; GABA release; Glutamate release; Hippocampus; Synaptosomes

Mesh:

Substances:

Year:  2015        PMID: 26452489      PMCID: PMC4648793          DOI: 10.1007/s11302-015-9476-1

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  26 in total

1.  Purinergic modulation of [(3)H]GABA release from rat hippocampal nerve terminals.

Authors:  R A Cunha; J A Ribeiro
Journal:  Neuropharmacology       Date:  2000-04-27       Impact factor: 5.250

2.  Activation of Trk neurotrophin receptors in the absence of neurotrophins.

Authors:  F S Lee; M V Chao
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

3.  The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.

Authors:  C Zocchi; E Ongini; A Conti; A Monopoli; A Negretti; P G Baraldi; S Dionisotti
Journal:  J Pharmacol Exp Ther       Date:  1996-02       Impact factor: 4.030

4.  Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition.

Authors:  L V Lopes; R A Cunha; B Kull; B B Fredholm; J A Ribeiro
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

5.  [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.

Authors:  M F Jarvis; R Schulz; A J Hutchison; U H Do; M A Sills; M Williams
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

Review 6.  Brain-derived neurotrophic factor.

Authors:  Devin K Binder; Helen E Scharfman
Journal:  Growth Factors       Date:  2004-09       Impact factor: 2.511

7.  Brain-derived neurotrophic factor facilitates glutamate and inhibits GABA release from hippocampal synaptosomes through different mechanisms.

Authors:  Nuno Canas; Inês T Pereira; Joaquim Alexandre Ribeiro; Ana M Sebastião
Journal:  Brain Res       Date:  2004-07-30       Impact factor: 3.252

8.  Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes.

Authors:  Rithwick Rajagopal; Zhe-Yu Chen; Francis S Lee; Moses V Chao
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

9.  Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors.

Authors:  Maria J Diógenes; Natália Assaife-Lopes; António Pinto-Duarte; Joaquim A Ribeiro; Ana M Sebastião
Journal:  Hippocampus       Date:  2007       Impact factor: 3.899

10.  Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices.

Authors:  Maria José Diógenes; Catarina Cunha Fernandes; Ana Maria Sebastião; Joaquim Alexandre Ribeiro
Journal:  J Neurosci       Date:  2004-03-24       Impact factor: 6.167

View more
  9 in total

1.  Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease.

Authors:  Emrin Horgusluoglu-Moloch; Kwangsik Nho; Shannon L Risacher; Sungeun Kim; Tatiana Foroud; Leslie M Shaw; John Q Trojanowski; Paul S Aisen; Ronald C Petersen; Clifford R Jack; Simon Lovestone; Andrew Simmons; Michael W Weiner; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2017-08-18       Impact factor: 4.673

2.  BDNF-induced presynaptic facilitation of GABAergic transmission in the hippocampus of young adults is dependent of TrkB and adenosine A2A receptors.

Authors:  Mariana Colino-Oliveira; Diogo M Rombo; Raquel B Dias; Joaquim A Ribeiro; Ana M Sebastião
Journal:  Purinergic Signal       Date:  2016-02-20       Impact factor: 3.765

3.  Sigma-1 receptor modulates neuroinflammation associated with mechanical hypersensitivity and opioid tolerance in a mouse model of osteoarthritis pain.

Authors:  Mireia Carcolé; Sami Kummer; Leonor Gonçalves; Daniel Zamanillo; Manuel Merlos; Anthony H Dickenson; Begoña Fernández-Pastor; David Cabañero; Rafael Maldonado
Journal:  Br J Pharmacol       Date:  2019-09-12       Impact factor: 8.739

Review 4.  Neuroprotection of exercise: P2X4R and P2X7R regulate BDNF actions.

Authors:  Bing-Xin Sun; Ai-Shi Peng; Pei-Jie Liu; Min-Jia Wang; Hai-Li Ding; Yu-Shi Hu; Liang Kang
Journal:  Purinergic Signal       Date:  2022-07-11       Impact factor: 3.950

5.  Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington's disease.

Authors:  Maria Rosaria Domenici; Valentina Chiodi; Mirko Averna; Monica Armida; Antonella Pèzzola; Rita Pepponi; Antonella Ferrante; Michael Bader; Kjell Fuxe; Patrizia Popoli
Journal:  Purinergic Signal       Date:  2018-05-16       Impact factor: 3.765

6.  mTOR inhibitors rescue premature lethality and attenuate dysregulation of GABAergic/glutamatergic transcription in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.

Authors:  Kara R Vogel; Garrett R Ainslie; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2016-08-12       Impact factor: 4.982

Review 7.  Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors.

Authors:  R Brito; K C Calaza; D Pereira-Figueiredo; A A Nascimento; M C Cunha-Rodrigues
Journal:  Cell Mol Neurobiol       Date:  2021-03-17       Impact factor: 5.046

8.  A maestro role of adenosine A2A receptors in GABAergic synapses stabilization during postnatal neuronal maturation.

Authors:  Ana M Sebastião
Journal:  Purinergic Signal       Date:  2022-02-04       Impact factor: 3.950

9.  Mutually suppressive roles of KMT2A and KDM5C in behaviour, neuronal structure, and histone H3K4 methylation.

Authors:  Christina N Vallianatos; Brynne Raines; Robert S Porter; Katherine M Bonefas; Michael C Wu; Patricia M Garay; Katie M Collette; Young Ah Seo; Yali Dou; Catherine E Keegan; Natalie C Tronson; Shigeki Iwase
Journal:  Commun Biol       Date:  2020-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.